Myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement in Vietnam: a case report and literature review

被引：0
|
作者：
Chu, Tan-Huy [1 ,2 ]
Huynh, Thien-Ngon [1 ]
Nguyen, Kim-Son [1 ,2 ]
Phu, Chi-Dung [1 ,2 ]
机构：
[1] Blood Transfus Hematol Hosp, Ho Chi Minh City, Vietnam
[2] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam
来源：
HEMATOLOGY TRANSFUSION AND CELL THERAPY | 2024年 / 46卷 / 04期
关键词：
8P11; PONATINIB;
D O I：
10.1016/j.htct.2023.04.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：498 / 502
页数：5
相关论文
共 50 条
  • [1] Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement
    Umino, Kento
    Fujiwara, Shin-ichiro
    Ikeda, Takashi
    Toda, Yumiko
    Ito, Shoko
    Mashima, Kiyomi
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Iekuni
    Ohmine, Ken
    Muroi, Kazuo
    Kanda, Yoshinobu
    HEMATOLOGY, 2018, 23 (08) : 470 - 477
  • [2] Myeloid/lymphoid neoplasms with FGFR1 rearrangement
    Strati, Paolo
    Tang, Guilin
    Duose, Dzifa Y.
    Mallampati, Saradhi
    Luthra, Rajyalakshmi
    Patel, Keyur P.
    Hussaini, Mohammad
    Mirza, Abu-Sayeef
    Komrokji, Rami S.
    Oh, Stephen
    Mascarenhas, John
    Najfeld, Vesna
    Subbiah, Vivek
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    Daver, Naval
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1672 - 1676
  • [3] Myeloid and lymphoid neoplasms with FGFR1 rearrangement-one case report and lecture review
    Li Yulong
    Shang Baojun
    Zhai Yaping
    Chen Xiangli
    Shi Jie
    Lei Pingchong
    Cheng Wei
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2011, 8 (02): : 300 - 304
  • [4] Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement
    Freyer, Craig W.
    Hughes, Mitchell E.
    Carulli, Alison
    Bagg, Adam
    Hexner, Elizabeth
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 351 - 359
  • [5] A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1)
    Gotlib, Jason
    Kiladjian, Jean-Jacques
    Vannucchi, Alessandro
    Rambaldi, Alessandro
    Reiter, Andreas
    Shomali, William
    George, Tracy I.
    Patel, Jay L.
    Colucci, Philomena
    Walker, Chris
    Zhen, Huiling
    Verstovsek, Srdan
    BLOOD, 2021, 138
  • [6] Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLNFGFR1): A US Real-World Retrospective Cohort Study
    Parasuraman, Shreekant
    Teschemaker, Anna
    Kish, Jonathan K.
    Savill, Kristin M.
    Colucci, Philomena
    BLOOD, 2022, 140 : 6854 - 6855
  • [7] Early presentation of hypogonadotropic hypogonadism due to a mutation of fibroblast growth factor receptor-1 (FGFR1) (case report)
    Guemas, Isabelle
    De Roux, Nicolas
    Chauvet, Genevieve
    Weill, Jacques
    HORMONE RESEARCH, 2006, 65 : 95 - 95
  • [8] Myeloid/lymphoid neoplasm with FGFR1 rearrangement
    Germans, Sharon Koorse
    Chen, Mingyi
    BLOOD, 2021, 138 (10) : 912 - 912
  • [9] Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor
    Verstovsek, S.
    Subbiah, V.
    Masarova, L.
    Yin, C. Cameron
    Tang, G.
    Manshouri, T.
    Asatiani, E.
    Daver, N. G.
    ANNALS OF ONCOLOGY, 2018, 29 (08) : 1880 - 1882
  • [10] Myeloid and Lymphoid Neoplasm With Abnormalities of FGFR1 Presenting With Trilineage Blasts and RUNX1 Rearrangement: A Case Report and Review of Literature
    Kumar, Kirthi R.
    Chen, Weina
    Koduru, Prasad R.
    Luu, Hung S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (05) : 738 - 748
12345